Figure 1.
Figure 1. Cumulative incidence of relapse (CIR) at 3 years for infant MLL-rearranged ALL patients with high or low FLT3 activation.

Cumulative incidence of relapse (CIR) at 3 years for infant MLL-rearranged ALL patients with high or low FLT3 activation.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal